Full text
3/2026
vol. 43
Letter to the Editor
Drug reaction with eosinophilia and systemic symptoms or peripheral T-cell lymphoma? That is the question
Clinical Department of Internal Disease, Dermatology and Allergology in Zabrze, Medical University of Silesia in Katowice, Poland
Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland
Tumour Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland
Adv Dermatol Allergol 2026; XLIII (3): 326–329
Data publikacji online: 2026/07/20
Article file
- Calle AM, Aguirre N, Ardila JC, Cardona Villa R. DRESS syndrome: a literature review and treatment algorithm. World Allergy Organization J 2023; 16: 100673.
- Roujeau JC, Dupin N. Virus reactivation in drug reaction with eosinophilia and systemic symptoms (DRESS) results from a strong drug-specific immune response. Allergy Clin Immunol Pract 2017; 5: 811-2.
- Oluwasanjo A, Kartan S, Johnson W, et al. Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS). Cancer Treat Res 2019; 176: 83-98.
- Mangana J, Guenova E, Kerl K, et al. Angioimmunoblastic T-cell lymphoma mimicking drug reaction with eosinophilia and systemic symptoms (DRESS Syndrome). Case Rep Dermatol 2017; 9: 74-9.
- Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996; 15: 250-7.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
